IntelliScript
Put some data-driven swagger into your risk assessment decision-making
We invent insurance software solutions that clarify risk and opportunity with speed and precision—so you can fearlessly lead your business forward.
See more. Fear less.
The most data, the best interpretation. Get clear, condition-specific vision for life and health insurance underwriting, risk adjustment, and clinical trials eligibility. Then move forward with confidence.
Irix® Suite
Identified data interpretation for a panoramic view of individual risk
The Irix Suite of insurtech products doesn’t just modernize your underwriting and claims management workflows. It vastly widens your vision on business risk while narrowing in on individual cases that make all the difference in performance, profitability, and growth.
Curv® Suite
Deidentified data interpretation for a broader view of the group risk terrain
When it comes to identifying unknown risks within groups of almost any size, the Curv Suite of predictive models delivers the unprecedented insight and analysis you need to stay competitive and profitable.
Resources and Events
White Paper
Quantifying the value of new-member HCC coding improvements to ACA plans
Accurately coding new members improves patient outcomes and an ACA plan’s bottom lines. The proof is here, in a formula you can apply yourself.
Read more
Webinar
From uninsurable to opportunity: The evolving mortality of hepatitis C, HIV, and cystic fibrosis
Underwriting is an ever-changing, highly nuanced discipline—and guidelines must keep up.
Read more
Join the smartest team in insurtech.
Push your talents to the max. As part of global Milliman, IntelliScript takes on some of the world’s weighty problems by developing technology that helps more people get the insurance coverage they need or participate in clinical trials that advance the field of medicine. Our work matters, and so do you. Join us—and start contributing at a whole new level.
Let's put risk in its place.
Got a problem to solve? Every solution begins with a conversation. We should talk.
